Surf Bio

About:

Surf Bio develops therapeutic solutions for diabetes, oncology, infectious diseases, and gene therapy.

Top Investors: Perceptive Advisors, Bill & Melinda Gates Foundation, Breakout Ventures

Description:

Surf Bio is a preclinical biopharmaceutical company leveraging a breakthrough next-generation surfactant to develop enhanced therapeutic solutions for diabetes, oncology, infectious diseases, gene therapy, and other therapeutic areas.

Total Funding Amount:

$17.6M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Palo Alto, California, United States

Founded Date:

2021-01-01

Founders:

Bryan Mazlish, Jennifer Schneider

Number of Employees:

1-10

Last Funding Date:

2024-04-30

IPO Status:

Private

Industries: